Winclove CLEAR for recurrent urinary tract infections in wome

• Conditions: (Recurrent) Urinary Tract Infections / (Recidiverende) UrineweginfectiesCystitis / CystitisQuality of Life / Levenskwaliteit&#8195

• Registration Number: NL-OMON25899
• Lead Sponsor: This study is performed at the research facility of CR2O by Prof. Dr. Eric Claassen (Principal Investigator) and Drs. Joost Flach (Coordinating Investigator).

Brief Summary

The results of this study showed a significant improvement on the UTI-QoL questionnaire in the CLEAR group compared with control. No publication is available yet.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Other
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

In order to be eligible for inclusion, a subject must meet all

of the following criteria:

Exclusion Criteria

A potential subject who meets any of the following criteria will be

excluded from participation in this study:

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. The differences in QoL between treatment arms according<br>to UTI-QoL-questionnaire data and SF-36 scores after the<br>intervention period.<br /><br>2. The difference in UTI incidence between treatment arms,<br>as measured by the mean number of patient-reported UTI<br>episodes during the intervention period.<br /><br>3. The difference in UTI symptom severity between<br>treatment arms, as measured by mean Symptom & Burden<br>questionnaire scores during the intervention period.